The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Clinical Trial Expert Discussion: Study Design for Microbiome Therapies
Clinical & Manufacturing

Clinical Trial Expert Discussion: Study Design for Microbiome Therapies

SEP 28, 2021
Evelo Biosciences Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis
Clinical & Manufacturing

Evelo Biosciences Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis

SEP 27, 2021
Synlogic Announces Positive Phase 2 Data Demonstrating Reduction in Plasma Phenylalanine Levels in Patients with Phenylketonuria
Clinical & Manufacturing

Synlogic Announces Positive Phase 2 Data Demonstrating Reduction in Plasma Phenylalanine Levels in Patients with Phenylketonuria

SEP 20, 2021
MD Anderson and SNIPR BIOME collaborate to advance next-generation CRISPR microbiome therapeutics
Finance

MD Anderson and SNIPR BIOME collaborate to advance next-generation CRISPR microbiome therapeutics

SEP 15, 2021
Finding more accurate signals and stronger leads for developing microbiome interventions
Pharma & Human Health

Finding more accurate signals and stronger leads for developing microbiome interventions

SEP 13, 2021
EMA & FDA Apply a Similar Mindset When Providing Scientific Advice For Live Biotherapeutic Product Development
Pharma & Human Health

EMA & FDA Apply a Similar Mindset When Providing Scientific Advice For Live Biotherapeutic Product Development

SEP 13, 2021
Common medications accumulate in gut bacteria, which may reduce drug effectiveness and alter the gut microbiome
Pharma & Human Health

Common medications accumulate in gut bacteria, which may reduce drug effectiveness and alter the gut microbiome

SEP 9, 2021
EnteroBiotix Raises over $21m in Series A Financing to Advance its Microbiome Drug Pipeline
Finance

EnteroBiotix Raises over $21m in Series A Financing to Advance its Microbiome Drug Pipeline

SEP 7, 2021
Adaptive Phage Therapeutics Announces Licensing Agreement with the Walter Reed Army Institute of Research
Finance

Adaptive Phage Therapeutics Announces Licensing Agreement with the Walter Reed Army Institute of Research

AUG 31, 2021
Microbes turn back the clock as research discovers their potential to reverse aging in the brain
Editor's Choice

Microbes turn back the clock as research discovers their potential to reverse aging in the brain

AUG 31, 2021
5 Tips for Making the Most of your Microbiome Analysis
Pharma & Human Health

5 Tips for Making the Most of your Microbiome Analysis

AUG 25, 2021